ethical considerations
antipsychotic drug side effects
staff reactions to aggression
lithium
opioid intoxication
anhydonia
lack of pleasure - negative sympton of schizophrenia
brain in compulsive substance use
basal forebrain and part of the amygdala - compulsivity
first: euphoria; later: no euphoria - only want to not feel bad
r/t opioid and gaba receptors
DSM criteria: phobia
activity and the brain
information about body’s activity is conveyed to SCN through indirect projections from brainstem arousal nuclei (BAN)
local feedback inhibition from other hypothalamc areas (dorsomedial nucleus -DSM)
right to treatment in least restrictive setting
testimonial privilege
addiction: use despite harm
common attitude/behavior-related triggers of schizophrenia
manifestations of corticostriatal thalamic cortical loop
hoarding Dx
incompetence
ethical decision-making
SSRIs: OCD, anxiety, MDD
Dose: OCD (80 mg) >>> anxiety (40) >>> MDD (20)
caffeine and nicotine in schizophrenia
manifestations of fear via amygdala-centered circuit
depression
medical certification
commitment made on decision of physician
depression among medical patients
documentation of AMA requests